正电子发射断层扫描在肺癌评估中的使用和误用。
The use and misuse of positron emission tomography in lung cancer evaluation.
机构信息
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Keck School of Medicine of USC, 2020 Zonal Avenue, IRD Room 723, Los Angeles, CA 90033, USA.
出版信息
Clin Chest Med. 2011 Dec;32(4):749-62. doi: 10.1016/j.ccm.2011.08.012.
Abstract
This article discusses the potential benefits and limitations of positron emission tomography (PET) for characterizing lung nodules, staging the mediastinum, identifying occult distant metastasis, determining prognosis and treatment response, guiding plans for radiation therapy, restaging during and after treatment, and selecting targets for tissue sampling. The key findings from the medical literature are presented regarding the capabilities and fallibilities of PET in lung cancer evaluation, including characterization of pulmonary nodules and staging in patients with known or suspected non-small-cell lung cancer. The discussion is limited to PET imaging with fluorodeoxyglucose.
摘要
本文讨论了正电子发射断层扫描（PET）在肺结节特征描述、纵隔分期、隐匿性远处转移的识别、预后和治疗反应判断、放射治疗计划指导、治疗期间和治疗后的再分期以及组织取样靶点选择方面的潜在优势和局限性。重点介绍了关于氟脱氧葡萄糖 PET 在肺癌评估中的作用和局限性的医学文献中的关键发现，包括对已知或疑似非小细胞肺癌患者肺结节的特征描述和分期。讨论仅限于氟脱氧葡萄糖 PET 成像。
相似文献
1
The use and misuse of positron emission tomography in lung cancer evaluation.正电子发射断层扫描在肺癌评估中的使用和误用。
Clin Chest Med. 2011 Dec;32(4):749-62. doi: 10.1016/j.ccm.2011.08.012.
2
Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery.接受根治性手术的IIIA-N2期非小细胞肺癌患者在接受或未接受放疗的诱导化疗后，正电子发射断层扫描-计算机断层扫描的解读及预后价值
Medicine (Baltimore). 2015 Jun;94(24):e955. doi: 10.1097/MD.0000000000000955.
3
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.F18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在非小细胞肺癌潜在根治性手术后患者中的临床价值：241例患者的经验
Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.
4
Positron emission tomography in lung cancer.肺癌的正电子发射断层扫描
Semin Nucl Med. 2002 Oct;32(4):240-71. doi: 10.1053/snuc.2002.126059.
5
[Current status of 18F-FDG PET in predicting outcome of cancer therapy].[18F-FDG PET在预测癌症治疗结果中的现状]
Zhonghua Zhong Liu Za Zhi. 2004 Oct;26(10):577-80.
6
Positron emission tomography imaging in nonsmall-cell lung cancer.非小细胞肺癌的正电子发射断层扫描成像
Cancer. 2007 Nov 15;110(10):2155-68. doi: 10.1002/cncr.23051.
7
Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.正电子发射断层扫描/计算机断层扫描在肺癌分期、预后和治疗反应评估中的应用。
J Thorac Imaging. 2011 May;26(2):132-46. doi: 10.1097/RTI.0b013e3182128704.
8
Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer.联合增强计算机断层扫描和 18 氟-2-脱氧-D-葡萄糖正电子发射断层扫描在非小细胞肺癌的诊断和分期中的应用。
Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):43-50. doi: 10.1053/j.semtcvs.2011.05.003.
9
FDG-PET imaging in the management of non-small-cell lung cancer.18F-氟脱氧葡萄糖正电子发射断层显像在非小细胞肺癌管理中的应用
Ann Oncol. 2002 Mar;13(3):357-60. doi: 10.1093/annonc/mdf106.
10
[Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy].[使用F18-氟脱氧葡萄糖正电子发射断层扫描评估可疑恶性肺病变]
Rev Med Chil. 2005 May;133(5):583-92. doi: 10.4067/s0034-98872005000500011. Epub 2005 Jun 17.
引用本文的文献
1
Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration.退伍军人医疗管理局中未进行病理确诊的早期非小细胞肺癌立体定向体部放疗的应用及结果
Adv Radiat Oncol. 2021 Apr 20;6(4):100707. doi: 10.1016/j.adro.2021.100707. eCollection 2021 Jul-Aug.
2
Intraoperative Molecular Imaging in Lung Cancer: The State of the Art and the Future.肺癌术中分子成像：现状与未来
Mol Ther. 2018 Feb 7;26(2):338-341. doi: 10.1016/j.ymthe.2018.01.013. Epub 2018 Feb 2.
3
Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.肺癌个体化运动管理和 PET/CT 引导放疗的挑战与机遇：综述与展望。
Clin Transl Med. 2012 Aug 31;1(1):18. doi: 10.1186/2001-1326-1-18.
本文引用的文献
1
Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning.低剂量 CT 扫描肺癌筛查中使用正电子发射断层扫描和体积倍增时间的联合应用。
Thorax. 2011 Apr;66(4):315-9. doi: 10.1136/thx.2010.136747. Epub 2010 Dec 17.
2
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.使用来自 PET 和动态对比增强 MRI 的成像标志物监测非小细胞肺癌对血管生成抑制剂治疗的反应。
J Nucl Med. 2011 Jan;52(1):48-55. doi: 10.2967/jnumed.110.078261. Epub 2010 Dec 13.
3
Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.诱导治疗后临床 IIIA 期非小细胞肺癌患者的生存：年龄、纵隔降期和肺切除范围是独立预测因素。
J Thorac Cardiovasc Surg. 2011 Jan;141(1):48-58. doi: 10.1016/j.jtcvs.2010.07.092. Epub 2010 Nov 18.
4
PET scans in radiotherapy planning of lung cancer.肺癌放射治疗计划中的 PET 扫描。
Radiother Oncol. 2010 Sep;96(3):335-8. doi: 10.1016/j.radonc.2010.07.002. Epub 2010 Jul 23.
5
Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.肺癌筛查中假阳性测试结果的累积发生率：一项随机试验。
Ann Intern Med. 2010 Apr 20;152(8):505-12, W176-80. doi: 10.7326/0003-4819-152-8-201004200-00007.
6
Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project.氟脱氧葡萄糖正电子发射断层扫描测量的原发肿瘤标准化摄取值对非小细胞肺癌生存具有预后价值：欧洲肺癌工作组为国际肺癌研究协会分期项目进行的系统评价和荟萃分析更新。
J Thorac Oncol. 2010 May;5(5):612-9. doi: 10.1097/JTO.0b013e3181d0a4f5.
7
Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature.氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）是否适合评估非小细胞肺癌的新辅助治疗？系统文献复习的证据。
J Surg Oncol. 2010 May 1;101(6):486-94. doi: 10.1002/jso.21525.
8
A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage.诱导治疗后 IIIa 期肺癌再分期的系统评价：病理分期的预测。
J Thorac Oncol. 2010 Mar;5(3):389-98. doi: 10.1097/JTO.0b013e3181ce3e5e.
9
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.18F-氟脱氧葡萄糖摄取的 PET 扫描与可切除的临床ⅠA 期非小细胞肺癌患者的预后。
Chest. 2010 May;137(5):1150-6. doi: 10.1378/chest.09-2356. Epub 2009 Dec 28.
10
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review.正电子发射断层扫描 18F-氟代脱氧葡萄糖摄取与手术治疗 I 期非小细胞肺癌患者预后的关系：系统评价。
J Thorac Oncol. 2009 Dec;4(12):1473-9. doi: 10.1097/JTO.0b013e3181bccbc6.
Zotero 插件